TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...
THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...
Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today an update to the ArteraAI Prostate Test ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
The Independent on MSN
New blood test could show if prostate cancer treatment is failing
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
7d
Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’
A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results